{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:54:19Z","timestamp":1790729659035,"version":"4.1.0"},"reference-count":137,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2006,1,20]],"date-time":"2006-01-20T00:00:00Z","timestamp":1137715200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2006,3]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Haemophilia A and B are inherited bleeding disorders whose diagnosis and management is generally well established and best provided by specialists in a comprehensive care setting. Patients may be put at unnecessary risk if appropriate expertise is not sought for the management of accidents and surgery. The delivery of a high quality comprehensive service to patients with bleeding disorders depends upon defined standards and a network of haemophilia centres in the UK with similar models in other countries. In developing countries, despite a shortage or absence of treatment products, development of local expertise results in an improved outlook and reduction in mortality. Optimal care for severe haemophilia includes accurate diagnosis, early and adequate factor replacement for bleeding episodes and the provision of prophylaxis from an early age to prevent joint bleeding and the consequent arthropathy. Haemophilia treatment is expensive resulting in considerable inequity in provision of care across the world. Despite decades of experience, optimal treatment levels are not robustly defined. Transfusion\u2010transmitted infections continue to have a significant impact on patient management. The development of inhibitory antibodies seriously complicates the management both in morbidity and cost. While gene therapy has not yet produced the hoped\u2010for cure, new technologies will produce improved products.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2005.05952.x","type":"journal-article","created":{"date-parts":[[2006,1,20]],"date-time":"2006-01-20T16:18:51Z","timestamp":1137773931000},"page":"671-682","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Optimal haemophilia care <i>versus<\/i> the reality"],"prefix":"10.1111","volume":"132","author":[{"given":"Paula H. B.","family":"Bolton\u2010Maggs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,2,13]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(80)90659-5"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2257.1983.tb01348.x"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-05-1446"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-07-2908"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01463.x"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.2001.00510.x"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2004.10.045"},{"key":"e_1_2_8_9_1","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1160\/TH04-08-0485","article-title":"Factor VIII efficient and specific non\u2010covalent binding to PEGylated liposomes enables prolongation of its circulation time and haemostatic efficacy","volume":"93","author":"Baru M.","year":"2005","journal-title":"Thrombosis and Haemostasis"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/9780470987124.ch34"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.1998.440532.x"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2005.01107.x"},{"key":"e_1_2_8_13_1","first-page":"563","article-title":"Safety, tolerability, and antiviral effects of BILN2061, a novel HCV serine protease inhibitor, after oral treatment over 2\u2003days in patients with chronic hepatitis C, genotype 1, with advanced liver fibrosis","volume":"304","author":"Benhamou Y.","year":"2002","journal-title":"Hepatology"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.9.s1.3.x"},{"key":"e_1_2_8_15_1","first-page":"691","article-title":"Modern treatment of haemophilia","volume":"73","author":"Berntorp E.","year":"1995","journal-title":"Bulletin of the World Health Organization"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.9.s1.17.x"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.9.s1.12.x"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2004.00998.x"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.2000.00381.x"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2004.00994.x"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1613376"},{"key":"e_1_2_8_22_1","first-page":"2428","article-title":"A multicenter study of recombinant factor VIII (recombinate): safety, efficacy, and inhibitor risk in previously untreated patients with hemophilia A. The Recombinate Study Group","volume":"83","author":"Bray G.L.","year":"1994","journal-title":"Blood"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-05-1426"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)11290-6"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1355-0691.2004.00874.x"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1006\/mthe.2001.0305"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2005.01072.x"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2005.01074.x"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2004.00984.x"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1614449"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)05413-5"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200402200-00020"},{"key":"e_1_2_8_33_1","volume-title":"Organisation of Haemophilia Centres","author":"Department of Health","year":"1976"},{"key":"e_1_2_8_34_1","volume-title":"Provision of Haemophilia Treatment and Care","author":"Department of Health","year":"1993"},{"key":"e_1_2_8_35_1","first-page":"494","article-title":"Factor VIII half\u2010life and clinical phenotype of severe hemophilia A","volume":"90","author":"Dijk K.","year":"2005","journal-title":"Haematologica"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2005.01124.x"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05546.x"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.2002.00626.x"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01689.x"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-01-0314"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.2000.00417.x"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.2000.00057.x"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2004.01010.x"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2004.01006.x"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cll.2004.05.009"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2004.01047.x"},{"key":"e_1_2_8_47_1","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1160\/TH04-08-0510","article-title":"Hepatitis C in haemophiliacs","volume":"92","author":"Franchini M.","year":"2004","journal-title":"Thrombosis and Haemostasis"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2004.00869.x"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.2003.00759.x"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0955-3886(98)00024-1"},{"key":"e_1_2_8_51_1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1055\/s-0038-1646370","article-title":"Genetic basis of hemophilia A","volume":"66","author":"Gitschier J.","year":"1991","journal-title":"Thrombosis and Haemostasis"},{"key":"e_1_2_8_52_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2003-37936"},{"key":"e_1_2_8_53_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.42.5.744"},{"key":"e_1_2_8_54_1","article-title":"Influence of the type of factor VIII concentrate on the incidence of factor VIII inhibitors in previously untreated patients with severe hemophilia A","author":"Goudemand J.","year":"2005","journal-title":"Blood"},{"key":"e_1_2_8_55_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.9.s1.6.x"},{"key":"e_1_2_8_56_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.1998.440558.x"},{"key":"e_1_2_8_57_1","doi-asserted-by":"publisher","DOI":"10.1002\/9780470987124.ch13"},{"key":"e_1_2_8_58_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01460.x"},{"key":"e_1_2_8_59_1","doi-asserted-by":"publisher","DOI":"10.1002\/9780470987124.ch35"},{"key":"e_1_2_8_60_1","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-83-11-2897"},{"key":"e_1_2_8_61_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1982.tb03856.x"},{"key":"e_1_2_8_62_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2004.00982.x"},{"key":"e_1_2_8_63_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.6.1727"},{"key":"e_1_2_8_64_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2005.01111.x"},{"key":"e_1_2_8_65_1","doi-asserted-by":"publisher","DOI":"10.1159\/000056713"},{"key":"e_1_2_8_66_1","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-199907000-00009"},{"key":"e_1_2_8_67_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1985.tb07353.x"},{"key":"e_1_2_8_68_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1614415"},{"key":"e_1_2_8_69_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2004.01042.x"},{"key":"e_1_2_8_70_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1615387"},{"key":"e_1_2_8_71_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2001-16893"},{"key":"e_1_2_8_72_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.1999.00328.x"},{"key":"e_1_2_8_73_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01631.x"},{"key":"e_1_2_8_74_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.2000.00427.x"},{"key":"e_1_2_8_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)15486-X"},{"key":"e_1_2_8_76_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.02828.x"},{"key":"e_1_2_8_77_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2005.01130.x"},{"key":"e_1_2_8_78_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2005.01070.x"},{"key":"e_1_2_8_79_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.2003.00708.x"},{"key":"e_1_2_8_80_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1355-0691.2004.00875.x"},{"key":"e_1_2_8_81_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.9.s1.15.x"},{"key":"e_1_2_8_82_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1538-7836.2003.00483.x"},{"key":"e_1_2_8_83_1","doi-asserted-by":"publisher","DOI":"10.1002\/9780470987124.ch48"},{"key":"e_1_2_8_84_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.2001.00559.x"},{"key":"e_1_2_8_85_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2005.01112.x"},{"key":"e_1_2_8_86_1","first-page":"1547","volume-title":"Nathan and Oski's Hematology of Infancy and Childhood","author":"Montgomery R.R.","year":"2003"},{"key":"e_1_2_8_87_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2005.00921.x"},{"key":"e_1_2_8_88_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-02-0589"},{"key":"e_1_2_8_89_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2004.00934.x"},{"key":"e_1_2_8_90_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.1992.tb00546.x"},{"key":"e_1_2_8_91_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1351-8216.2001.00134.x"},{"key":"e_1_2_8_92_1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1182\/blood.V2.2.185.185","article-title":"Contribution to the pathogeneisis of hemophilia","volume":"2","author":"Pavlovsky A.","year":"1947","journal-title":"Blood"},{"key":"e_1_2_8_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16811-6"},{"key":"e_1_2_8_94_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1655911"},{"key":"e_1_2_8_95_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2001.00471.x"},{"key":"e_1_2_8_96_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2004.00987.x"},{"key":"e_1_2_8_97_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01367.x"},{"key":"e_1_2_8_98_1","doi-asserted-by":"publisher","DOI":"10.1007\/PL00014347"},{"key":"e_1_2_8_99_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196512302732701"},{"key":"e_1_2_8_100_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2005.01142.x"},{"key":"e_1_2_8_101_1","doi-asserted-by":"publisher","DOI":"10.1002\/9780470987124.ch36"},{"key":"e_1_2_8_102_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.1995.tb00104.x"},{"key":"e_1_2_8_103_1","first-page":"371","volume-title":"Haemostasis and Thrombosis","author":"Rizza C.","year":"1981"},{"key":"e_1_2_8_104_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2001.00521.x"},{"key":"e_1_2_8_105_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V81.8.2180.2180"},{"key":"e_1_2_8_106_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2004.00980.x"},{"key":"e_1_2_8_107_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2004.03154.x"},{"key":"e_1_2_8_108_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.1999.00300.x"},{"key":"e_1_2_8_109_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199012273232604"},{"key":"e_1_2_8_110_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2005.01156.x"},{"key":"e_1_2_8_111_1","first-page":"437","article-title":"Mortality among males with hemophilia: relations with source of medical care. The Hemophilia Surveillance System Project Investigators","volume":"96","author":"Soucie J.M.","year":"2000","journal-title":"Blood"},{"key":"e_1_2_8_112_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.2001.00484.x"},{"key":"e_1_2_8_113_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.1999.00337.x"},{"key":"e_1_2_8_114_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.05110.x"},{"key":"e_1_2_8_115_1","doi-asserted-by":"publisher","DOI":"10.1080\/10245330512331390320"},{"key":"e_1_2_8_116_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01407.x"},{"key":"e_1_2_8_117_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.1998.00161.x"},{"key":"e_1_2_8_118_1","doi-asserted-by":"publisher","DOI":"10.1016\/0027-5107(67)90029-2"},{"key":"e_1_2_8_119_1","volume-title":"Cochrane Database Systamatic Review","author":"Stobart K.","year":"2005"},{"key":"e_1_2_8_120_1","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-2-65"},{"key":"e_1_2_8_121_1","volume-title":"Arrangements for the Care of Persons Suffering from Haemophilia and Related Disorders. Health memorandum","author":"UK Ministry of Health","year":"1968"},{"key":"e_1_2_8_122_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2004.00983.x"},{"key":"e_1_2_8_123_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-10-3867"},{"key":"e_1_2_8_124_1","doi-asserted-by":"publisher","DOI":"10.1002\/9780470987124.ch17"},{"issue":"1","key":"e_1_2_8_125_1","first-page":"S125","article-title":"Development of anaphylactic shock in haemophilia B patients with inhibitors","volume":"9","author":"Warrier I.","year":"1998","journal-title":"Blood Coagulation and Fibrinolysis"},{"key":"e_1_2_8_126_1","volume-title":"Global Survey on Hemophilia","author":"WFH","year":"2000"},{"key":"e_1_2_8_127_1","volume-title":"WFH Global Survey","author":"WFH","year":"2000"},{"key":"e_1_2_8_128_1","first-page":"1","volume-title":"Guidelines for the Management of Hemophilia","author":"WFH","year":"2005"},{"key":"e_1_2_8_129_1","volume-title":"Fact Sheets","author":"WFH","year":"2005"},{"key":"e_1_2_8_130_1","volume-title":"World Federation of Hemophilia Annual Report 2004","author":"WFH","year":"2005"},{"key":"e_1_2_8_131_1","volume-title":"World Federation of Hemophilia Report on the Global Survey 2004","author":"WFH","year":"2005"},{"key":"e_1_2_8_132_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01406.x"},{"key":"e_1_2_8_133_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.2003.00780.x"},{"key":"e_1_2_8_134_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.2003.00781.x"},{"key":"e_1_2_8_135_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-10-3050"},{"key":"e_1_2_8_136_1","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1055\/s-0038-1657681","article-title":"Absence of inhibitors in previously untreated patients with severe haemophilia A after exposure to a single intermediate purity factor VIII product","volume":"78","author":"Yee T.T.","year":"1997","journal-title":"Thrombosis and Haemostasis"},{"key":"e_1_2_8_137_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1355-0691.2004.00877.x"},{"key":"e_1_2_8_138_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-06-2181"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2005.05952.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2005.05952.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T04:42:36Z","timestamp":1697431356000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2005.05952.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2,13]]},"references-count":137,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["10.1111\/j.1365-2141.2005.05952.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2005.05952.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,2,13]]},"assertion":[{"value":"2006-02-13","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}